Hospice News May 30, 2024
When it comes to hospice acquisitions, buyers and sellers’ expectations on price tags are becoming more aligned.
A surge of deals in 2021 and 2022 led to record-high valuations in the space with multiples reaching in excess of 30x in some instances. While many buyers were willing to pay that premium, some stepped out of the market due to the high valuations.
But deal volume has largely declined in late 2023 and early 2024, and valuations are starting to come down.
“[Buyers and sellers] are definitely coming closer. The peak chasm certainly was in the second half of 2022, but we’re now approaching two years hence. There’s been a reset since then,” said Mark Kulik, senior managing director for The...